What Evolution Can Teach Us About Cancer

1

Like wombats and wildebeests, cancer cells are continually adapting to their environment. If that environment includes drugs meant to kill cancer cells, some cells may adapt so well, they eventually gain the ability to grow and divide in spite of those drugs – a process known as drug resistance. The result can be a resurgence of tumors that once were held in check by treatment.

In a video from a TEDMED 2012 Conference, Dana-Farber’s Franziska Michor, PhD, explains how she and her colleagues are using advanced mathematical formulas to see if changing the schedule for a medication can reduce the chance that a tumor will become drug-resistant. Her talk (and her story in Paths of Progress magazine, also available as an iPad app) illustrates one way that researchers are harnessing mathematics to pursue the war on cancer.

Watch the TEDMED 2012 talk

Watch the Q&A with Franziska Michor, PhD

Comments Sort By Newest

One thought on “What Evolution Can Teach Us About Cancer

Leave a Reply

Your email address will not be published. Required fields are marked *

Blue Captcha Image
Refresh

*

Latest Tweets

Dana-Farber @danafarber
What is a PARP Inhibitor and how is it used to stop some cancer cells? https://t.co/b8TcFkCIx0 #ScienceIllustrated https://t.co/Zt06wW24ZP
Dana-Farber @danafarber
Symptoms of throat cancer include changes in the voice, trouble swallowing, and ear pain. More signs to look for: https://t.co/E3qRFBACHg
Dana-Farber @danafarber
A Behind the Scenes Look at the People Helping to Usher in New Cancer Therapies: A Nurse’s Story - https://t.co/48GI2l4rrp

Make An Appointment

For adults: 877-442-3324

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.